The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.
A study of three jurisdictions found that unannounced drills using professional actors posing as patients exposed gaps in how healthcare facilities.
Dr. Charlotte Ying highlights the growing demand for non-invasive aesthetic treatments, with Venus Nova emerging as a versatile solution for body.